API's
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
BP/USP/JP
C15H14N4O6S2
(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
97519-39-6
410.425 g/mol
Cephalosporins
Antibiotic - Cephalosporins
| Appearance | White to off-white crystalline powder |
|---|---|
| Solubility | Freely soluble in water, sparingly soluble in methanol, practically insoluble in ethanol, acetone, and ether |
| Melting Point | 208–212°C |
| pH | 3.5 to 4.5 |
Ceftibuten is a third-generation cephalosporin antibiotic that is orally administered. It is typically used to treat acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial otitis media, pharyngitis, and tonsilitis.
Ceftibuten exerts its bactericidal action by binding to essential target proteins of the bacterial cell wall. This binding leads to inhibition of cell-wall synthesis.
| Attribute | Why Salius Pharma Is a Good Choice |
|---|---|
| Quality Certification | WHO GMP, ISO 9001:2015, FDA audited facilities |
| Affordability & Generic Access | Cost competitive generics for global supply |
| Export Experience | Proven record of supplying globally |
When you order from Salius Pharma, you receive more than just a product — you receive a complete, professionally prepared package that meets international regulatory and quality expectations.
We ensure prompt and reliable shipping worldwide. Delivery times vary depending on destination, order volume, and regulatory requirements.
7 to 21 business days from dispatch, depending on your location.
Ceftibuten is widely used for respiratory tract infections, such as tonsillitis, otitis media, bronchitis, and for urinary tract infections. Its spectrum covers both Gram-negative and select Gram-positive bacteria.
Salius Pharma provides complete regulatory documentation, including DMFs, CoAs, and CTD/eCTD dossiers, aligned with the requirements of agencies.
Long-term use is not generally advised. Extended treatment may cause bacterial resistance, microbiota imbalance, and should be done only under strict medical supervision.
Ceftibuten inhibits the synthesis of bacterial cell walls, causing cell lysis and death. It is effective as an oral third-generation cephalosporin against common community-acquired pathogens.
Common effects include diarrhea, nausea, abdominal pain, and rashes.
Looking to source Ceftibuten or other high-quality pharmaceutical products?
We’re here to help.
Whether you need Active Pharmaceutical Ingredients (APIs), finished formulations, or regulatory support,
our team is ready to provide dependable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.